Embolism (Embolus)

01/01/1995 - "These randomised prospective open studies showed a significant reduction of S and systematic embolism in patients receiving low dose of warfarin (W), even in the elderly, as compared to placebo, and the incidence of hemorrhagic complications was also very low. "
01/01/2018 - "The patient's symptoms improved over time, and warfarin was started with close cardiopulmonary assessments for indicators of cement embolus removal. "
12/01/2008 - "To evaluate the efficacy of warfarin in preventing systemic embolism (embolism to limbs or viscera) in patients with AF. "
08/01/2012 - "The purpose of this study was to assess the risk and timing of thrombo-embolism after warfarin treatment interruption. "
11/01/2020 - "The second pulmonary embolus occurred while the patient was on coumadin, though achieving a therapeutic international normalized ratio was challenging. "

08/01/1988 - "Two patients had pulmonary embolus treated successfully with anticoagulants. "
04/01/1978 - "Use of prosthetic valves, despite constant improvement in their manufacture and systematic administration of anticoagulant drugs, are always complicated by embolisms (4 to 7% of cases at present). "
12/01/2021 - "Direct oral anticoagulants (DOAC) use remains challenging in obese patients treated for Venous-Thrombo-Embolism (VTE) due to the paucity of prospective and dedicated studies. "
06/15/1993 - "The value of anticoagulants has been demonstrated by large controlled studies, but it is important to know that a very strong anticoagulant treatment is unnecessary to reduce the risk of embolism. "
08/16/1969 - " incidence of recurrent embolism in the trial group is significantly lower than that found in a retrospective study of 50 patients treated with anticoagulants only. "

08/01/2012 - "Dabigatran 150 mg bid may be preferred for patients with a high risk for embolism."
09/01/2019 - "Postoperative PVS thrombosis causes embolisms, and dabigatran has been effective in preventing postoperative recurrences. "
04/01/2012 - "This economic evaluation suggests that the use of dabigatran etexilate as a first-line treatment for the prevention of stroke and systemic embolism is likely to be cost-effective in eligible UK patients with AF."
05/01/2011 - "This study demonstrates that dabigatran etexilate is a highly cost-effective alternative to current care for the prevention of stroke and systemic embolism among Canadian AF patients."
01/01/2022 - "Dabigatran continues to be safe and well tolerated in patients with NVAF for stroke and systemic embolism prevention and continues to be prescribed appropriately. "

01/01/2020 - "In the Reducing Post-Discharge Venous Thrombo-Embolism Risk (MARINER) study, extended use of rivaroxaban halved symptomatic VTE in high-risk medical patients compared with placebo. "
08/01/2017 - "Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF."
01/01/2022 - "There were no cases of non-central nervous system systemic embolism, and 735 (67.2%) patients persisted with rivaroxaban treatment for 1 year. "
09/25/2019 - "A significantly higher rate of reduction of the embolus size was observed in the rivaroxaban group than in the control group (P=0.0216). "
09/25/2019 - "The number and sizes of the emboli were measured at two time points: immediately after and 3 h after the embolus injection in the rivaroxaban-treated mice (n =6) and untreated mice (n =7). "

12/01/2010 - "In patients presenting RMVD with AF for less than a year and no previous embolism, Aspirin is little effective in preventing TE. "
09/03/2003 - "Embolism is a major complication of IE, and studies in animal models have shown that platelet inhibition with aspirin can lead to more rapid vegetation resolution and a lower rate of embolic events. "
07/01/2023 - "Aspirin was found to reduce mortality risk and embolism events. "
06/01/2017 - "Aspirin significantly decreased pulmonary artery pressure, improve pathological changes in the embolism, and decreased the expression of CX3CL1/CX3CR1 and CX3CL1/NF-κB. "
05/28/2014 - "COM reduced pulmonary embolus mortality by 27, 40 and 53%, vs. 47% for aspirin. "

02/01/2009 - "Despite the use of anti-vitamin K during the first trimester with 42.86% of the patients, the anticoagulation was effective with the entire cases excepted one who died by lung embolism. "
01/01/2020 - "The prevention of embolisms in "valvular" AF should perform with Vitamin K antagonists (VKA). "
03/01/2009 - "The current approach for deciding the duration of vitamin K antagonist (VKA) treatment after an episode of venous thrombo-embolism (VTE) is mainly based on the characteristic of the index event (3 months or longer in case of unknown/persistent risk factors, 3 months or less in case of removable causes). "
09/01/2004 - "We also recommend systemic anticoagulation with UFH followed by long-term vitamin K antagonist (VKA) in patients with embolism [Grade 1C]). "
10/01/2002 - "Prevention of embolism has for many years been obtained with vitamin K antagonists for which the clinical evidence is overwhelming. "

05/23/2021 - "In our case report, we present a patient who had VTE in the form of a saddle pulmonary embolus while on apixaban."
10/01/2019 - "The NAXOS study will provide routine clinical practice data on the effectiveness and safety profiles of apixaban vs other NOACs and VKAs in the prevention of stroke and systemic embolism in adult patients with NVAF in clinical practice conditions in France."
07/01/2017 - "Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial."
11/07/2023 - "There was no difference between apixaban 5 mg and 2.5 mg groups in the risk of stroke/systemic embolism (3.3 versus 3.0 events per 100 person-years; incidence rate difference, 0.2 [95% CI, -1.0 to 1.4] events per 100 person-years; subdistribution hazard ratio, 1.01 [95% CI, 0.59-1.73]), or death (9.9 versus 9.4 events per 100 person-years; incidence rate difference, 0.5 [95% CI, -1.6 to 2.6] events per 100 person-years; hazard ratio, 1.03 [95% CI, 0.77-1.38]). "
01/01/2020 - "Regular-dose apixaban (5 mg twice daily) associated with reduced rates of ischemic stroke or systemic embolism, whereas no such association was present for those prescribed the reduced dose (2.5 mg twice daily). "

06/01/1982 - "Heparin led to a greater reduction in embolus weight compared to control animals, but in the short time interval of this study it did not lead to improvement, in the respiratory or haemodynamic parameters. "
01/01/2001 - "There is some doubt that heparin is effective for the prevention of systemic embolism in patients with mechanical heart valves. "
12/01/1999 - "Heparin and oral anticoagulation have been shown to be effective in reducing recurrence and death in venous thrombo-embolism. "
11/01/1998 - "There is some doubt that heparin is effective for the prevention of systemic embolism in patients with mechanical heart valves. "
11/01/1998 - "There is a concern about the efficacy of unfractionated heparin in the prevention of arterial embolism in pregnant women with mechanical heart valves. "

02/15/2015 - "Edoxaban approved for embolism prevention."
01/01/2022 - "The combined endpoint of stroke/TIA/systemic embolism occurred at a rate of 1.7/100 patient-years (95% CI 1.3-2.3) in the intention-to-treat analysis and at 1.3/100 patient-years (95% CI 0.9-1.9) in the on-treatment analysis (censored 3 days after last edoxaban intake). "
01/01/2022 - "A 15-mg dose of edoxaban consistently decreased the event rates for stroke or systemic embolism with no interaction with age (80-84 years, hazard ratio [HR], 0.41; 95% CI, 0.13-1.31; P = .13; 85-89 years, HR, 0.42; 95% CI, 0.17-0.99; P = .05; ≥90 years, HR, 0.23; 95% CI, 0.08-0.68; P = .008; interaction P = .65). "
05/01/2019 - "Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?"
01/01/2022 - "Regardless of frailty status, among Japanese patients with AF aged 80 years or older who were ineligible for standard OACs, once-daily 15-mg edoxaban was associated with reduced incidence of stroke or systemic embolism and may be a suitable treatment option for these patients."

02/01/2013 - "Oral direct thrombin inhibitors were associated with an improved major and CRNM bleeding profile (both comparisons: RR 0.88, 95 % CI 0.78-0.98, P = 0.02) and a significant reduction in stroke and systemic embolism (against controls: RR 0.79, 95 % CI 0.66-0.93, P = 0.006; against VKAs: RR 0.78, 95 % CI 0.66-0.93, P = 0.006). "
09/01/2009 - "Indirect systemic and oral direct factor Xa and oral direct thrombin inhibitors are currently being developed for the prevention of embolism in patients with AF."
03/27/2014 - "Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation."
03/01/2014 - "[Analysis of the Cochrane Review: Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation. "
08/01/2013 - "Dabigatran is a direct thrombin inhibitor that reduces the risk of systemic embolism in patients with nonvalvular atrial fibrillation. "

07/01/1994 - "It can be concluded from these data, that the majority of patients receiving anticoagulation profit from this therapy, however, a complete protection against arterial embolism or reoccurrence of thrombi cannot be reached. "
10/01/2021 - "IATT combined with conventional sequential therapy was beneficial in the recovery from other serious HA embolism complications. "
04/01/2011 - "Patients with large artery occlusion due to a septic embolus can be successfully treated with endovascular therapies in select patients."
01/01/2005 - "The distal embolism protection method is superior to the aspiration method for prevention of embolization after PCI with stenting for AMI, in terms of tissue level reperfusion in myocardial recanalization therapy."
01/01/1991 - "Over a period of 18 months this therapy was effective in preventing relapses of thrombo-embolism and other complications. "

07/01/2005 - "This catheter is easier to use than similar devices available to date and is extremely effective in the removal of large intracoronary thrombi, thus providing protection against distal embolism during angioplasty procedures."
01/01/2016 - "The use of the Export Advance catheter showed better performance using a distal protection filter in this in vitro experiment, and its use might be more effective in preventing distal embolisms in combination with a distal protection filter."
04/01/2015 - "Percutaneous interventions, including thromboaspiration and catheter directed thrombolysis, can be used effectively to treat renal artery embolism. "
01/01/2021 - "A novel treatment using a guide extension catheter and distal protection device for refractory coronary embolism: case report."
11/10/2023 - "To explore the safety and efficacy of Sofia Plus distal access catheter tip shaping for treatment of acute middle cerebral artery embolism. "

04/01/1988 - "If the embolus is recent, intraarterial fibrinolytic treatment or percutaneous embolectomy can be attempted, but these techniques are not of proven efficacy. "
05/01/2005 - "An aggressive approach to large pulmonary embolus, including rapid diagnosis and prompt surgical intervention, has improved results with surgical embolectomy. "
01/01/1992 - "Mean long term survival in the embolus group was 35 months (range 1-108 months) with a high mortality rate in the first 6 months after embolectomy and improved survival after this. "
09/01/1976 - "It was observed that embolectomy carried out at 2, 3, and up to 5 hours after embolism was relatively safe and effective. "
11/17/1964 - "[HAS TRANSSTERNAL EMBOLECTOMY IMPROVED THE SURGICAL PROGNOSIS IN FULMINATING LUNG EMBOLISM?]."

01/01/2016 - "In this AIS embolism flow model with Solitaire thrombectomy, the Lazarus Funnel resulted in a significant increase in recanalization and significant reduction in distal emboli without increase in time to recanalization."
11/01/2022 - "Mechanical thrombectomy using a standard device has been effective for acute cerebral large-vessel occlusions, particularly those due to cardiogenic embolism. "
11/18/2006 - "Aspiration thrombectomy to remove a left main coronary artery saddle embolus resulted in immediate haemodynamic improvement with no requirement for angioplasty or repeat bypass grafting. "
12/01/2015 - "The Spider filter EPD can be safe and effective in protecting patients from distal branch embolism when they undergo an endovascular thrombectomy procedure."
11/01/1985 - "The efficacy of conventional anticoagulation and surgical thrombectomy in controlling embolism and the risk of creating emboli during thrombectomy were also evaluated. "

01/01/2004 - "The year passed was characterized by wide introduction into clinical practice of stents coated with antirestenotic agents, substantial advances in pharmacological support and improvements of safety of coronary interventions, active studies of contrast induced nephropathy and assessment of novel devices for myocardial protection against distal embolism during interventions both on coronary arteries and vein grafts. "
01/01/2004 - "The year passed was characterized by wide introduction into clinical practice of stents coated with antirestenotic agents, substantial advances in pharmacological support and improvements of safety of coronary interventions, active studies of contrast induced nephropathy and assessment of novel devices for myocardial protection against distal embolism during interventions both on coronary arteries and vein grafts. "
09/01/2002 - "Herein we review the latest advances in PTCA and stent implantation in vein grafts, discuss the impact of new stent designs, temporary antiaggregatory regimes and mechanic embolus protection devices and point towards future directions, which may help to further improve safety and efficacy of percutaneous interventions in this challenging subgroup of lesions."
12/01/2005 - "To assess the technical feasibility and efficacy of distal embolus protection with an intra-aortic filter during stent-graft repair in a patient diagnosed with a shaggy aorta. "
01/01/2022 - "The result of this study showed us that the rate of same-side cranial embolism detected on cranial diffusion-weighted magnetic resonance imaging after carotid artery stenting performed with open-cell stent was higher than those of the carotid artery stenting procedure performed with closed-cell and hybrid-cell stents."